Intra-Cellular Therapies to Present at the 54th Annual Meeting of the American College of Neuropsychopharmacology
NEW YORK, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced two ITI-007 poster presentations at …